Discontinuation report BELSOMRA

Last updated on 2020-05-15 History
Report ID 115269
Drug Identification Number 02483513
Brand name BELSOMRA
Common or Proper name suvorexant tablets
Company Name MERCK CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) SUVOREXANT
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30TAB
ATC code N05CM
ATC description
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2020-05-14
Remaining supply date 2020-05-14
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-05-15 French Compare
v2 2020-05-15 English Compare
v1 2020-05-15 English Compare

Showing 1 to 3 of 3